GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Pck1 | increases expression | EXP | | 6480464 | CTD | troglitazone results in increased expression of PCK1 mRNA | PMID:12732648 | Pck1 | decreases expression | ISO | Pck1 (Rattus norvegicus) | 6480464 | CTD | troglitazone results in decreased expression of PCK1 mRNA | PMID:10446394 PMID:11597575 | Pck1 | increases expression | ISO | PCK1 (Homo sapiens) | 6480464 | CTD | troglitazone results in increased expression of PCK1 mRNA | PMID:28934090 | Pck1 | multiple interactions | ISO | Pck1 (Rattus norvegicus) | 6480464 | CTD | [troglitazone co-treated with 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one] results in decreased expression of PCK1 mRNA; [troglitazone co-treated with Sirolimus] results in decreased expression of PCK1 mRNA; [troglitazone co-treated with wortmannin] results in decreased expression of PCK1 mRNA | PMID:10446394 | | ||||||||||||||||||||||
| Go Back to source page | Continue to Ontology report |